Quarter Financials
Nektar Therapeutics (NKTR)
$0.718
-0.03 (-3.38%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -60 | -59 | -159 | -90 | -146 | -130 | -126 | -123 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -3,201 | -3,142 | -3,082 | -2,923 | -2,833 | -2,687 | -2,558 | -2,432 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -1 | -0 | -1 | -4 | -6 | -3 | -3 | -3 |
|---|
| Net PPE | 86 | 103 | 109 | 175 | 178 | 179 | 181 | 183 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | -295 | -233 | -288 | -145 | -93 | -154 | -48 | -172 |
|---|
| Intangible and Goodwill | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
|---|